• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Acasti Pharma, Inc. - Common Stock (NQ:ACST)

3.370 UNCHANGED
Last Price Updated: 3:44 PM EDT, Oct 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Acasti Pharma, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
50 Biggest Movers From Yesterday ↗
December 23, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. (NASDAQ: ACST) jumped 52.3% to close at $1.69 on... 
Via Benzinga
News headline image
ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $6 ↗
December 22, 2021
After an Oppenheimer upgrade, shares of ACST stock are soaring higher by more than 25%. Why exactly is the investment firm bullish? 
Via InvestorPlace
News headline image
Mid-Afternoon Market Update: CalAmp Drops After Q3 Results; Red Cat Holdings Shares Surge ↗
December 22, 2021
Toward the end of trading Wednesday, the Dow traded up 0.51% to 35,674.84 while the NASDAQ rose 0.53% to 15,422.40. The S&P also rose, gaining 0.60% to 4,677.06. The U.... 
Via Benzinga
News headline image
Acasti Pharma Falls To Support, Stages Huge Rebound ↗
May 07, 2021
Shares of Acasti Pharma, Inc. (NASDAQ:ACST) fell ... 
Via Benzinga
News headline image
Mid-Day Market Update: Nasdaq Rises Over 100 Points; Allakos Shares Plunge ↗
December 22, 2021
Midway through trading Wednesday, the Dow traded up 0.41% to 35,637.05 while the NASDAQ rose 0.80% to 15,463.85. The S&P also rose, gaining 0.67% to 4,680.45. The U.S. has the... 
Via Benzinga
News headline image
32 Stocks Moving In Wednesday's Mid-Day Session ↗
December 22, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple award blanket purchase agreement by the United... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021 ↗
December 22, 2021
Upgrades According to Loop Capital, the prior rating for Williams-Sonoma Inc (NYSE: 
Via Benzinga
News headline image
See Why Acasti Pharma Shares Are Trading Over 20% Higher? ↗
December 22, 2021
Oppenheimer initiated coverage of Acasti Pharma Inc (NASDAQ: ACST) with an Outperform rating and $6 price target. The analyst sees over 400% upside for... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
December 22, 2021
We've reached the halfway point of the week and we're starting it with an overview of the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
News headline image
20 Stocks Moving in Wednesday's Pre-Market Session ↗
December 22, 2021
Gainers BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered into a Master Service Agreement with PRC Clinical,... 
Via Benzinga
News headline image
Acasti Pharma's Hemorrhage Candidate Shows Encouraging PK Profile In Healthy Volunteers ↗
December 02, 2021
Acasti Pharma Inc (NASDAQ: ACST) has announced interim results from its pivotal pharmacokinetic (PK) bridging study of GTX-104 for Subarachnoid Hemorrhage. Based... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance ↗
December 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-... 
Via Benzinga
News headline image
55 Biggest Movers From Yesterday ↗
September 01, 2021
Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it... 
Via Benzinga
News headline image
Why Shares of Acasti Pharma Slumped Tuesday ↗
August 31, 2021
The clinical-stage pharmaceutical company completed its merger with Grace Therapeutics last week. 
Via The Motley Fool
News headline image
28 Stocks Moving in Monday's Pre-Market Session ↗
August 30, 2021
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) rose 86.1% to $9.87 in pre-market trading after jumping over 80% on Friday. The company recently reported a Q2 loss of $5.13 per share... 
Via Benzinga
News headline image
21 Stocks Moving in Wednesday's Pre-Market Session ↗
August 25, 2021
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported... 
Via Benzinga
News headline image
26 Stocks Moving in Wednesday's Pre-Market Session ↗
July 14, 2021
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares rose 35.6% to $3.54 in pre-market trading after jumping around 12% on Tuesday. Oxbridge Re Holdings Limited (NASDAQ: OXBR) shares... 
Via Benzinga
News headline image
45 Biggest Movers From Yesterday ↗
June 24, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First... 
Via Benzinga
News headline image
31 Stocks Moving In Wednesday's Mid-Day Session ↗
June 23, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613. Orphazyme A/S (NASDAQ: ORPH)... 
Via Benzinga
News headline image
26 Stocks Moving in Wednesday's Pre-Market Session ↗
June 23, 2021
Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss. SeaChange International... 
Via Benzinga
News headline image
Is Now The Time To Buy Crypto & Penny Stocks? ↗
May 19, 2021
What began as a small crack in crypto has opened up into a full-blown wound. 
Via Talk Markets
News headline image
ACASTI PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Acasti Pharma Inc. - ACST
May 12, 2021
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
20 Stocks Moving in Monday's Pre-Market Session ↗
May 10, 2021
Gainers Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as Chief Revenue Officer. SemiLEDs Corporation (... 
Via Benzinga
News headline image
Acasti Pharma To Acquire Grace Therapeutics: Highlights ↗
May 07, 2021
Acasti Pharma Inc (NASDAQ: ACST) has agreed to acquire privately-held Grace Therapeutics Inc in an all-stock transaction. After the consummation of... 
Via Benzinga
News headline image
Acasti Pharma Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Acasti Pharma Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ACST
May 07, 2021
From Halper Sadeh LLP
Via Business Wire
News headline image
20 Stocks Moving in Tuesday's Pre-Market Session ↗
April 20, 2021
Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) rose 108.2% to $9.16 in pre-market trading after dropping more than 10% on Monday. Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap